Inventia Healthcare recalls 25mg Chlorthalidone tablets due to failed dissolution specifications. Rx-only medication with specific batch numbers and expiration dates. Consumers should contact the manufacturer for details.
“Inventia Healthcare Chlorthalidone Tablets Recall: Failed Dissolution Specifications.” GovInfoNow, updated August 10, 2026. https://govinfonow.com/recall/31216-inventia-healthcare-chlorthalidone-tablets-recall-failed-dissolution-specifications. Based on FDA recall #D-0610-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0610-2026%22&limit=1).
The FDA announced on June 5, 2026, that Inventia Healthcare Limited is recalling Chlorthalidone Tablets, USP, 25 mg due to failed dissolution specifications. The voluntary Class II recall affects 11,460 bottles distributed nationwide.
The recalled Chlorthalidone Tablets, USP, 25 mg failed dissolution specifications. The FDA has not reported specific incidents or injuries associated with this recall in the provided record.
Context
GovInfoNow's records show Inventia Healthcare Limited had one other recall on record since September 3, 2026, for Chlorthalidone due to failed dissolution specifications. Other recent recalls of similar products include Teva Metoprolol Succinate Tablets Recall (January 29, 2026), Teva Metoprolol Succinate Extended-Release Tablets Recall (January 29, 2026), and Golden State Medical Recalls Prasugrel HCl 10mg Tablets (August 21, 2026).
How to tell if you have this one
Check for the product name 'Chlorthalidone Tablets, USP, 25 mg' on the label. Look for batch numbers RISA24001 (100 tablets) or RISB24002 (1000 tablets) and expiration date 04/2027.
Brand
Inventia Healthcare
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Identify the batch number and expiration date on the label to confirm if the product is recalled.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “U.S. Nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 19 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0610-2026 (June 5, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0610-2026 to see it in context.
Plain-language summary written by qwen3:4b on August 10, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.